SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The crow with knife community is rallying around the project's multichain expansion and deflationary burn mechanism, viewing it as a top contender in the meme coin sector. Supporters are actively promoting its organic growth and technical integration, framing it as a standout asset worth accumulating.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is drawing intense focus as investors weigh the potential synergy of a rumored SpaceX-Tesla partnership and the ambitious 'Terafab' in-house silicon project against concerns over slowing EV sales, valuation, and aggressive capital expenditure. The community remains deeply polarized, with bulls positioning for a potential squeeze fueled by SpaceX IPO anticipation and AI infrastructure expansion, while bears continue to highlight declining earnings and significant execution risks.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech 100 is drawing significant attention from retail investors due to its direct exposure to high-profile private companies like SpaceX and Anthropic, with many users speculating on the impact of a potential SpaceX IPO. While bullish sentiment centers on its unique access to these assets, community discourse remains divided as skeptics point to the stock's substantial premium over its net asset value and volatility compared to other space-sector proxies.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is trending as investors debate whether the company's AI-driven platform and mortgage innovation represent a high-growth turnaround or a business model inherently vulnerable to high mortgage rates and macroeconomic pressures. The community remains intensely polarized, with bulls highlighting the firms increasing acquisition volume and leadership strategy, while bears continue to focus on the company's profitability challenges and its sensitivity to broader market volatility.

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is trending as investors debate whether the low-market-cap meme coin is a legitimate scaling opportunity or a high-risk pump-and-dump scheme. The community is actively tracking whale wallet movements and liquidity patterns, with participants weighing the potential for massive gains against warnings of a total rug pull.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is trending as retail traders scramble for exposure to AI leaders like OpenAI, Anthropic, and SpaceX, fueling a meme-like frenzy that has sent the stock soaring despite warnings of extreme overvaluation relative to its net asset value. Community members are actively debating the sustainability of this parabolic run, with many highlighting that the limited tradable float due to lockup periods is creating intense volatility and aggressive short-squeeze dynamics.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop shares are under intense scrutiny as investors weigh solid profitability and significant cash reserves against the lack of a clear acquisition roadmap and a controversial pay package proposal for the CEO. The community remains deeply polarized, with some anticipating a strategic transformation while others express frustration over stagnant price action and the absence of a formal earnings call.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas is trending as investors digest a surge in revenue guidance alongside a strategic acquisition of World View, sparking intense debate between bulls citing long-term defense contract potential and skeptics focused on historical dilution and volatile price action. The community is heavily focused on the upcoming earnings call, weighing recent analyst price target hikes against the stock's persistent intraday volatility and the ongoing impact of short interest.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is currently a major focus for traders as they debate the impact of potential token supply burns versus broad market volatility and ongoing regulatory discussions. The community remains divided, with some investors accumulating at current levels in anticipation of future expansion, while others express caution regarding the long-term viability of the meme coin sector.

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.

Terns Pharmaceuticals Inc

Terns Pharmaceuticals is experiencing significant market attention following positive Phase 1 data for its CML drug, TERN-701, which has fueled speculation regarding its best-in-disease potential. Investors are actively debating the stock's valuation, the likelihood of a buyout by major pharmaceutical players, and the impact of recent analyst upgrades, while managing concerns over long-term clinical development costs and potential future capital raises.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review

Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive...

Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities

Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities PR Newswire SAN DIEGO, March 12, 2026 SAN...

Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026

Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026 Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026 PR Newswire SAN DIEGO, Feb. 23...

Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update

Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update PR Newswire SAN DIEGO, Feb. 12, 2026...

Illustration showing chimeric antigen receptor (CAR) T cells (blue and green) being used to treat non-small cell lung cancer (NSCLC). | Representative image: Getty Images

Why Did Aethlon Medical Stock Tumble Over 12% Today?

Aethlon Medical's stock drew investor attention after the company announced a private placement and warrant inducement deal. 

Equity

Aethlon Medical's stock drew investor attention after the company announced a private placement and warrant inducement deal. 


Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million

Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million Aethlon Medical Announces Pricing of a Private...

Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier Binds to Extracellular Vesicles in Long COVID patient samples and Decreases Inflammatory microRNAs

Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier Binds to Extracellular Vesicles in Long COVID patient samples and Decreases...

Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update

Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update PR Newswire SAN DIEGO, Nov. 12, 2025...

What to Expect from Aethlon Medical's Earnings

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025 Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference...

Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce on April 17, 1991 and is headquartered in San Diego, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$2.17	--	--	N/A
Q3 '25	-$2.75	-$2.45	10.91%	BEAT
Q2 '25	-$3.66	-$3.74	-2.09%	MISSED
Q1 '25	-$0.86	-$8.50	-887.30%	MISSED
Q4 '24	-$1.07	-$3.22	-200.00%	MISSED

AEMD
Aethlon Medical Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest AEMD News

AEMDAethlon Medical Inc